AURA at $7.125: Sell Consensus, Shallow Bearish Tape, and a 42%-Win Engine Buy — WATCH With Three Numbers
Published · entry price $7.125 · machine-generated by the QuantLogix Thesis Engine and graded publicly at T+7/30/90 days · AURA charts & signals →
AURA sits at $7.125 inside a fully conflicted stack: analysts say Sell with a $5.92 target (−16.9% implied downside), technicals are bearish but shallow, and the LIVE engine reads Buy at 62/100 with a calibrated win probability of just 42%. No side clears the +5% per-call bar — the name's Healthcare × engine-Buy cohort measures +2.99% over 272 signals with a judged month at −2.15%, and the long-side cohort is unverified. We publish WATCH with hard triggers at $8.00, $6.50, and $5.92; a verified long cohort or a reclaimed 20-day SMA would upgrade the call.
Options expression
Thesis
- AURA holds above $6.50 through the T+30 grading window; a close below it falsifies the neutral-drift thesis.
- AURA does not close below the $5.92 consensus price target within 30 trading days.
- AURA closes above $8.00 within 30 trading days, confirming the LIVE engine's Buy read and arming a bullish upgrade.
- AURA's 5-day momentum turns positive (above 0%) before the T+30 grading, as the first tape confirmation of the engine's 62/100 signal.
Evidence Graph2 of 4 claims linked · 3 preserved sources
This graph uses only evidence frozen into the thesis at publication on 11/18/2026. “Retrieved source passage” is the preserved grounding excerpt the engine saw; “published note passage” is thesis context, not a source quote. Missing edges and dates remain visible.
AURA holds above $6.50 through the T+30 grading window; a close below it falsifies the neutral-drift thesis.
AURA does not close below the $5.92 consensus price target within 30 trading days.
AURA closes above $8.00 within 30 trading days, confirming the LIVE engine's Buy read and arming a bullish upgrade.
Legacy note context shares live, engine; support or opposition was not preserved.
Published note passage
Engine record. The LIVE Buy at 62/100 is mid-pack for the engine's healthcare coverage — its top conviction names scored 94 ([HRMY]) and 96 ([UTMD]).
Legacy note context shares live, engine; support or opposition was not preserved.
Published note passage
Engine record. The LIVE Buy at 62/100 is mid-pack for the engine's healthcare coverage — its top conviction names scored 94 ([HRMY]) and 96 ([UTMD]).
AURA's 5-day momentum turns positive (above 0%) before the T+30 grading, as the first tape confirmation of the engine's 62/100 signal.
Legacy note context shares 62, 100, engine; support or opposition was not preserved.
Published note passage
Engine record. The LIVE Buy at 62/100 is mid-pack for the engine's healthcare coverage — its top conviction names scored 94 ([HRMY]) and 96 ([UTMD]).
Legacy note context shares 62, 100, engine; support or opposition was not preserved.
Published note passage
Engine record. The LIVE Buy at 62/100 is mid-pack for the engine's healthcare coverage — its top conviction names scored 94 ([HRMY]) and 96 ([UTMD]).
Unmapped source register
1 sourceThese links were preserved in the note but cannot be honestly assigned to a specific claim.
Published note passage
s (rates, cycle, sector rotation) is attached to this name on the platform, and I will not invent one; the cycle-relevant fact on the record is that the engine's own healthcare book judged −2.15% in 2026-08 (see the [QL Startup Daily…
What changed
Complete, timestamped thesis history.
-
Thesis publishedWATCH · LOW conviction
Setup
This is user-requested initiation, not a model-driven screen pick, and the distinction matters: nothing in the request implies an edge, so the burden falls entirely on the tape. AURA prints at $7.125 inside a fully conflicted stack. Sell-side consensus is Sell with a $5.92 target; the technical tape is bearish but shallow; and the LIVE 5-factor engine reads Buy, 62/100, with a calibrated win probability of 42% — below a coin flip. One data-integrity flag before anything else: the quant context quotes the $5.92 target against a $6.34 reference price while the live print is $7.125. That anchor is stale, and the honest implied downside is −16.9% from live, not −6.6%. Under platform rules this note publishes as WATCH in any case — the Healthcare × engine-Buy cohort measures +2.99% over 272 signals, with a judged month at −2.15% (2026-08), below the +5% per-call alpha bar — so the only question is whether the evidence prices a side. It does not, and I will show why rather than hide behind the rule.
Evidence & Data
| Layer | Reading | Note |
|---|---|---|
| Composite signal | Neutral (−0.06) | Flat |
| RSI / MACD | 45.2 / 0.051 | Neutral-soft; MACD barely positive |
| 5d / 20d momentum | −2.54% / −3.79% | Mild deterioration |
| SMA trend | Bearish | Unbroken |
| News sentiment | 0 | No informational edge |
| Analyst consensus | Sell, PT $5.92 (−16.9% vs live) | Majority view |
| LIVE engine | Buy, 62/100, win prob 42% | Sub-coin-flip |
| Long cohort | 41.6% win, 406 signals | Unverified |
| Short cohort | 46.7% win, 892 signals | Verified but weak |
| Name cohort | +2.99%, 272 signals | Below +5% bar |
Analyst consensus, explicitly weighed. The majority recommendation is Sell with a $5.92 target, −16.9% below the live print. I take it seriously as the market's anchor — but note the contradiction: a name trading 17% above its consensus target while news sentiment is exactly zero and options flow shows no large positioning or whale orders. Someone is wrong — either the target is stale momentum-extrapolation, or the price is complacent.
Technical stack, explicitly weighed. RSI 45.2 is neutral-soft, MACD 0.051 barely positive, 5d momentum −2.54%, 20d −3.79%, SMA trend bearish. The stack points down, but shallowly — a drift, not a breakdown, and it justifies no direction on its own.
News and macro, explicitly weighed. News sentiment is 0 — no edge. No live macro series (rates, cycle, sector rotation) is attached to this name on the platform, and I will not invent one; the cycle-relevant fact on the record is that the engine's own healthcare book judged −2.15% in 2026-08 (see the QL Startup Daily briefing, 08/30/2026), so defensive-sector rotation is not currently paying this cohort.
Engine record. The LIVE Buy at 62/100 is mid-pack for the engine's healthcare coverage — its top conviction names scored 94 (HRMY) and 96 (UTMD). Graded calibration says BEARISH calls have averaged −2.2% and BULLISH +1.7%, and bearish research running against LIVE reads like this one was right only 30% of the time. The pre-policy directional record is −2.06% over 41 calls — the +5% bar exists because of it.
Consensus vs. variant perception. The consensus view is Sell into −16.9% of downside. This thesis disagrees with the confidence on both sides, not necessarily the direction: the Sell case extrapolates a shallow dip while price sits far above target with zero news and zero flow; the engine's Buy carries a 42% win probability and an unverified long cohort (41.6% over 406 signals). What the market is missing is that the distribution is wide and unverified in both tails — and a wide, unverified distribution cannot clear a +5% per-call bar from $7.125. That refusal is the product.
Scenario Analysis
| Scenario | Probability | Price path | Thesis impact |
|---|---|---|---|
| Drift: shallow bearish tape persists, no news, no flow | 50% | $7.125 → $7.00 (−1.8%) | WATCH vindicated; cohort's +2.99% regime continues |
| Bear: Sell consensus validates, slide toward target | 30% | $7.125 → $6.00 (−15.8%) | $5.92–$6.00 zone tested; bearish trigger arms |
| Bull: engine Buy wins, 20d SMA reclaimed | 20% | $7.125 → $8.00 (+12.3%) | Bullish upgrade candidate only if long cohort verifies |
EV = 0.5×$7.00 + 0.3×$6.00 + 0.2×$8.00 = $6.90, −3.2% vs current $7.125 — negative carry on an unverified distribution, and nowhere near the +5% bar.
Catalysts & Risks
Catalysts: a reclaim of the 20-day SMA with 5d momentum flipping positive (MACD at 0.051 is one bad session from flipping); a cohort re-judgment lifting the Healthcare × Buy mean above +5% with no month ≤ 0; verification of the long cohort (currently 41.6%, unverified, 406 signals); any whale options positioning — the tape currently has none, so flow arriving would itself be news. Risks: a close under **$6.
What Changes Our Mind
The WATCH view on AURA is predicated on the current state of market ambiguity, where technicals are drifting and the engine's Buy signal is statistically unverified. We would pivot to a constructive Bullish stance if the stock achieves a sustained reclaim of the 20-day SMA accompanied by a clear positive shift in 5-day momentum, signaling a definitive breakout from the present malaise. Crucially, this move must be supported by a tangible increase in institutional flow or whale options positioning, which are currently non-existent.
Conversely, we would shift to an aggressive Bearish stance if AURA closes decisively below the $6.50 level. A breach of this support would invalidate the engine's current Buy probability, confirming that the Sell-side consensus target of $5.92 is not merely stale, but an emerging gravity well. Finally, a formal re-judgment of the Healthcare × Buy cohort showing consistent performance above our +5% alpha hurdle would be required to transform this signal from a passive observation into an actionable high-conviction trade. Until these specific triggers occur, the risk-reward remains insufficient to warrant a directional departure from our neutral posture.
Related QuantLogix coverage
- HRMY Hits 94/100 — Top Conviction on the Signal Engine | QuantLogix
- UTMD Hits 96/100 Composite — Highest Signal Today | QuantLogix
- QL Startup Daily — 08/30/2026
More from QL Research
- REVOLUT · WATCH — Revolut — WATCH: A $115B Momentum Mark With No Gradeable Tape; $90B Is the Line
- TELEGRAM · WATCH — Telegram (Private): 1B Users at $28/User — the Legal Discount Is Overcharged but Not Yet Tradeable
- ALPHASENSE · WATCH — AlphaSense (Private, Last Mark $7.5B): The AI-Pricing Question Is the Whole Thesis — WATCH Until the S-1 Answers It
- WEALTHSIMPLE · WATCH — Wealthsimple (Private): 68% Growth, Fully Priced at CAD 13.8B — WATCH With a Hard Flow-Trigger
- MERCURY · WATCH — MERCURY — Constructive WATCH: Post-Beat Momentum Already Taxed; $80/$102 Triggers Decide the Side
- PBF · WATCH — PBF Energy: Record Quarter, a Flaring Event, and a Consensus That Contradicts Itself — WATCH at $67.60